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Abstract
Here, we describe a porous 3-dimensional collagen scaffold material that supports capillary
formation in vitro, and promotes vascularization when implanted in vivo. Collagen scaffolds
were synthesized from type I bovine collagen and have a uniform pore size of 80 μm. In
vitro, scaffolds seeded with primary human microvascular endothelial cells suspended in
human fibrin gel formed CD31 positive capillary-like structures with clear lumens. In vivo,
after subcutaneous implantation in mice, cell-free collagen scaffolds were vascularized by
host neovessels, whilst a gradual degradation of the scaffold material occurred over 8
weeks. Collagen scaffolds, impregnated with human fibrinogen gel, were implanted subcu-
taneously inside a chamber enclosing the femoral vessels in rats. Angiogenic sprouts from
the femoral vessels invaded throughout the scaffolds and these degraded completely after
4 weeks. Vascular volume of the resulting constructs was greater than the vascular volume
of constructs from chambers implanted with fibrinogen gel alone (42.7±5.0 μL in collagen
scaffold vs 22.5±2.3 μL in fibrinogen gel alone; p<0.05, n = 7). In the same model, collagen
scaffolds seeded with human adipose-derived stem cells (ASCs) produced greater
increases in vascular volume than did cell-free collagen scaffolds (42.9±4.0 μL in collagen
scaffold with human ASCs vs 25.7±1.9 μL in collagen scaffold alone; p<0.05, n = 4). In sum-
mary, these collagen scaffolds are biocompatible and could be used to grow more robust
vascularized tissue engineering grafts with improved the survival of implanted cells. Such
scaffolds could also be used as an assay model for studies on angiogenesis, 3-dimensional
cell culture, and delivery of growth factors and cells in vivo.
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Introduction
Engineered tissues are emerging as a viable approach to address the scarce supply of heterolo-
gous donor organs available for transplantation. However, vascularization is one of the great
challenges that tissue engineering faces in order to generate sizeable tissue and organ substi-
tutes that contain living cells [1]. In vascularized tissues, it is estimated that cells must be
located within 150–200 μm of the nearest capillary to survive and function optimally [2]. In
addition to access to oxygen and nutrients, vascular networks are needed for the removal of
carbon dioxide and other cellular waste products during metabolism [2]. Therefore, engineer-
ing functional tissues with clinically relevant thickness will require approaches to incorporate
vascular networks.
Several strategies have been explored to enhance tissue vascularization, including controlled
release of proangiogenic factors such as vascular endothelial growth factor (VEGF) and fibro-
blast growth factor-2 [3,4], but such approaches could be limited by the short half-life of proan-
giogenic factors. Recent studies have reported that by allowing vascular cells to form
rudimentary microvascular networks on biologically-derived scaffolds in vitro, it is possible to
achieve enhanced integration of the implanted graft with host vasculature [5–8]. This pre-vas-
cularization strategy generated ‘perfusable’ constructs that might improve survival of
implanted cells when transplanted in vivo.
Collagen is a major extracellular matrix (ECM) component that has been widely used for
constructive remodelling to facilitate cell growth and differentiation. The widespread use of
collagen across many clinical applications is due to its bio-inductive, and desirable mechanical
and degradable properties [9,10]. Collagen-based biomaterials in various formats have been
employed as cellular scaffolds for tissue repair and regeneration [11]. Scaffolds made of colla-
gen can support physiological processes in the course of healing and provide a platform for the
development of 3-dimensional (3D) functionally intact tissue constructs with vascular in-
growth, a component which is indispensable for survival of scaffold implanted cells. Type I
bovine collagen has been used to create porous biomaterials as a means for regenerating blad-
der tissues in an experimental model of bladder exstrophy [12,13] and is readily available. It is
therefore a suitable base material to fabricate a porous collagen scaffold.
In this current study, we sought to determine whether the collagen scaffold material could
support in vitro vascularization with human endothelial cells and facilitate extrinsic and intrin-
sic vascularization when implanted in vivo. We employed the murine subcutaneous implant
model to characterize the time course of endogenous cell infiltration and degradation of the
collagen scaffold in vivo. We then employed a more complex rat tissue engineering chamber
model to assess the potential of the collagen scaffolds to promote intrinsic vascularization and
as a bioactive cue for sustaining the proangiogenic paracrine activity of human adipose-derived
stem cells (ASCs) in vivo.
Materials and Methods
Synthesis and characterization of collagen scaffolds
The base collagen solutions were prepared as described previously [12]. Porous collagen scaf-
folds with an average pore size of 80 μmwere generated from a lyophilized collagen solution
(final concentration of 7 mg/mL). Briefly, 0.56 g of Type I bovine collagen isolated from cow
skin was added to 80 mL of 0.5 M acetic acid solution (Merck Millipore, Darmstadt, Germany).
The collagen solution was first frozen at -20°C for 24 hours, and then underwent a concen-
trated and lyophilized procedure to produce an interconnected porous structure. The pre-
formed porous collagen scaffolds were then treated with N-Ethyl-N'-(3-dimethylamino-
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propyl) carbodiimide (Sigma-Aldrich, MO, USA), a crosslinking agent, for 4 hours and washed
with phosphate buffered saline (PBS) three times. The scaffolds were then lyophilized again to
improved mechanical strength (Table 1). Collagen scaffolds in the shape of a disc with a
dimension of 8 mm diameter and 2 mm thickness (Fig 1A) were prepared for this study. The
surface and cross-section morphology of the scaffolds were examined by a scanning electron
microscope (Fig 1B).
To assess the mechanical properties of the collagen sponge, the collagen sample was fully
swollen in PBS solution before the mechanical strength measurements (tensile tests). In these
tests we mounted the collagen onto the load cell using adhesive sponge gasket between the load
cell and sample. The collagen membranes were cut into pieces (1 × 6 cm, n = 5) and the tensile
strengths of the samples were measured up to the point at which they broke. The mechanical
parameters of the samples were calculated and recorded automatically by using a material-test-
ing system (MTS; Eden Prairie, USA) at a crosshead speed of 5 mm/min.
The porosity of the collagen sponge was determined using Archimedes’ principle [14]. The
exterior volume (Vs) of the plug (1 cm × 1 cm) was measured using a Vernier caliper. The sam-
ple was then immersed in a pycnometer containing 99% ethanol solution. The actual volume
(Va) of the sample was calculated using the formula:
Va ¼ ðWwWoÞ  ðWt WpÞ0:789 g=cm3
Where Ww is the weight of the ethanol and the pycnometer, Wo is the dry weight of the pyc-
nometer, Wt is the combined weight of the ethanol, the pycnometer and the plug sample, Wp
is the combined weight of the dry pycnometer and dry plug sample, and 0.789 g/cm3 is the den-
sity of 99% ethanol solution. The porosity of the plug was then determined using the following
formula:
Porosity %ð Þ ¼ Vs Va
Vs
100%
Porosity values are expressed as means ± standard deviations (n = 5).
The water content (WC) of the collagen sponge was determined by swelling the sponge in a
pH 7.4 PBS at room temperature. After the sponge was equilibrated with PBS, the wet sponge
Table 1. Mechanical properties of collagen scaffold.
Water content 97.6±0.3 (%)
Porosity 74.4±7.1 (%)
Young’s modulus 31.1±1.5 (106gf/mm2)
Maximum elongation 3.4±0.2 (mm)
doi:10.1371/journal.pone.0149799.t001
Fig 1. The 3D architecture and pore size of porous collagen scaffolds. (A) A 3D collagen scaffold
measured to a diameter of 8 mm and a thickness of 2 mm. (B) Representative images captured by scanning
electron microscopy on the surface (left) and through a cross section (right) of collagen scaffold.
doi:10.1371/journal.pone.0149799.g001
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was blotted using filter paper to remove the water adherent to the sponge surface. The WC of
the sponge was calculated as following formula:
WC %ð Þ ¼ WwWd
Wd
100%
Where Ww andWd are the weights of the wet and dry sponge, respectively. The WC are
expressed as means ± standard deviations (n = 5).
Culture of human endothelial cells on collagen scaffolds and
assessment of vascularization in vitro
Primary human dermal blood microvascular endothelial cells (hMECs) and growth media
(EGM-2-MV) were purchased from Lonza (MD, USA). hMECs (5x105 cells) were resuspended
in 25 μL of human fibrinogen (15 mg/mL in PBS, Sigma-Aldrich) and dripped onto the upper
surface of collagen scaffolds sitting flat on a petri dish. Following passive uptake of the cell/
fibrinogen mixture, 25 μL of human thrombin (25 U/mL in PBS, Sigma-Aldrich) was added to
form the fibrin gel. Scaffolds were then transferred to a 24-well plate containing 2 mL growth
media and cultured for the specified time. Media was replaced after 2 days. At day 3, scaffolds
were harvested and fixed in 4% paraformaldehyde for 24 hours before subjection to tissue pro-
cessing and embedding in paraffin.
Culture of human ASCs on collagen scaffolds in vitro
Isolation and culture of human ASCs. Human ASCs were isolated as previously
described [15] following approval by St Vincent’s Hospital Human Ethics Committee
(HREC5203). Fat tissues were collected as part of routine medical surgery and patients have
given written informed consent for use of their tissues for research purpose. Briefly, aspirated
fat tissues were washed with PBS containing 100 mg/mL streptomycin and 100 U/mL penicillin
(Invitrogen, CA, USA), and minced into small pieces. Tissue fragments were washed once with
PBS and then digested in 3 volumes of Dulbecco’s Modified Eagle's Medium (DMEM; Invitro-
gen) containing 0.5 mg/mL collagenase I (250 U/mg; Worthington Biochemical, NJ, USA)
overnight with continuous shaking at 37°C. On the second day, cells were collected by centrifu-
gation (800 xg for 10 minutes), seeded in culture flasks and cultured overnight at 37°C with 5%
CO2 in growth media (DMEM supplemented with 10% fetal bovine serum (FBS, Sigma-
Aldrich), 2 mM glutamine (Invitrogen), 100 mg/mL streptomycin and 100 U/mL penicillin
(Invitrogen)). On the third day, attached cells were rinsed 3 times with PBS and cultured in
growth media until confluent. Confluent cells were subcultured by trypsinization at a 1:4 ratio.
We have confirmed that>95% of the isolated cells express mesenchymal surface markers
CD29, CD44 and CD90 by flow cytometry [15].
Generating the GFP-expressed ASCs by lentiviral gene delivery. The packaging system
for the production of lentiviral consisted of the following vectors: pCMV-ΔR8.91 plasmid,
pMD.G (envelope element) and pLKO_AS2/GFP (transfer vector). These vectors were
obtained from the National RNAi Core Facility (Taipei, Taiwan) as described previously [15].
Briefly, 6×105 293FT cells (Invitrogen) were seeded in a 6-cm culture dish and cultured for 24
hours. A mixture of the 3 vectors (2.5 μg of pCMV-ΔR8.91, 0.3 μg of pMD.G, and 2.5 μg of
pLKO_AS2/GFP) was prepared and transfected into 293FT cells using Lipofectamine 2000
(Invitrogen). The virus-containing media were collected at 48 hours after transfection. For len-
tivirus transduction, human ASCs were seeded in 6-well plates (1×105 per well) in growth
media. After overnight incubation, cells were treated with virus-containing media containing
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8 μg/mL polybrene (Sigma-Aldrich). The culture medium was removed at 24 hours post-infec-
tion and GFP positive cells were enriched (>99%) by FACSAria (BD Biosciences, CA, USA).
Scanning electron microscopy (SEM)
Twenty-four hours after cell seeding, the scaffolds were directly subjected to SEM (Philips
XL30 SEM, FEI Company, OR, USA) with an accelerating voltage of 24 kV at Melbourne
Advanced Microscopy Facility (Parkville, VIC, Australia).
Proliferation assay to assess cell growth in vitro
The growth of GFP-expressed human ASCs cultured in 3D collagen scaffolds or on collagen
coated (0.5 mg/mL; Invitrogen) plate was assessed by using alamarBlue assay. Briefly, GFP-
expressed human ASCs (1x106 cells) were seeded in collagen scaffolds as 3D culture or in
12-well tissue culture plates as 2D culture, and cultured over a period of 3 weeks. At day 0, 2, 7,
14 and 21, scaffolds were cut into small pieces and incubated with alamarBlue1 solution (Invi-
trogen) in a proportion of 1:10 (10 μL of alamarBlue1 reagent to 100 μL of culture media) for
1 hour at 37°C in a humidified atmosphere containing 5% CO2. Fluorescence signals were mea-
sured at an excitation wavelength at 530–560 nm and an emission wavelength at 590 nm using
a polarstar microplate reader (BMG Labtech, Australia) at 37°C.
Animal use
Ethics approval for this work was obtained from the St Vincent’s Hospital Animal Ethics Com-
mittee (#021/13), in accordance with the requirements of the Australian National Health and
Medical Research Council guidelines for the care and health of animals. The animals were sup-
plied from Animal Resources Centre, Perth, Australia. No mice or rats became ill prior to the
experimental endpoint. Minor stress induced by operation was looked for daily by observing
the motility, grooming and feeding behaviour. All surgery was performed under general anaes-
thesia (2% isoflurane), and all efforts were made to minimize suffering. In the experimental
endpoint, the mice or rats were euthanized using Lethobarb (200 mg/kg, intraperitoneal
injection).
Murine subcutaneous scaffold implantation to assess vascular infiltration
in vivo
The collagen scaffolds filled with normal saline were implanted subcutaneously on either side
of the dorsum of male C57B/L6 mice (10–12 weeks) under general anaesthesia (2% isoflurane).
Scaffolds were then harvested at 1, 2, 4 and 8 weeks post-implantation to evaluate the time
course of vascular infiltration and degradation of scaffold. At harvest, scaffolds were cleaned of
connective tissues and immediately fixed in 4% paraformaldehyde overnight before being sub-
jected to tissue processing and embedding in paraffin.
Rat tissue engineering chamber to assess vascular infiltration in vivo
An in vivo rat tissue engineering chamber was employed as previously described [16]. Male
Sprague Dawley rats weighing between 300–400 g were anesthetized with an inhalation of iso-
flurane. The femoral vessels were exposed through a longitudinal incision made on the medial
thigh. Intact left and right femoral artery and vein were separated from each other and from
the surrounding tissues over approximately a 2 cm distance and placed within an acrylic poly-
mer chamber (internal dimensions of 10×8×4 mm; Department of Chemical and Biomolecular
Engineering, University of Melbourne, Australia) by passing the intact vascular pedicle through
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openings at either end of the chamber, creating a flow-through model with an intact femoral
circulation. A lid was attached to the chamber base to create a protected volume space for tissue
growth. Each rat was implanted with two chambers (left and right femoral vessels); one con-
taining a collagen scaffold impregnated with 100 μL of human fibrinogen gel (15 mg/mL;
Sigma-Aldrich) and one with 100 μL of human fibrinogen gel alone to serve as a control.
To determine whether collagen scaffolds can be used to deliver cells with proangiogenic
paracrine activity, scaffolds were seeded with human ASCs and implanted into the rat tissue
engineering chambers. Male nude rats (CBH-rnu, 190–225 g) were purchased from the Animal
Resources Centre (Perth, Australia) and were used for implantation of chambers containing
either a collagen scaffold or a collagen scaffold pre-cultured for 48 hours with 1x106 GFP-
expressed human ASCs.
At 2–4 weeks post-implantation, tissue constructs were harvested from the animals under
general anesthesia. Tissues were blotted dry and weighed. The volume of tissue constructs was
determined by a volume displacement measurement method [17,18]. Tissues were fixed in 4%
paraformaldehyde overnight. Tissue constructs were then divided into four equal transverse
sections and paraffin embedded for routine histology and immunohistochemistry.
Immunohistochemistry
Paraffin embedded sections (5 μm) were stained with eosin-hematoxylin (H&E) and Masson’s
Trichrome to examine general tissue morphology. To identify hMECs in scaffolds cultured in
vitro, endogenous peroxidase activity of sections was quenched with 3% H2O2 for 5 minutes.
Sections were then subjected to enzymatic-mediated antigen retrieval with 0.1% Proteinase
K (pH 7.8, Dako, Hamburg, Germany) for 8 minutes. The sections were blocked with 10%
goat serum (Sigma-Aldrich) for 30 minutes, and then incubated with mouse anti-human
CD31 (10.3 μg/mL, Dako) for 60 minutes. Sections were then incubated with biotinylated
rabbit-anti-mouse secondary antibody (2.9 μg/mL; Dako) for 60 minutes and avidin-biotiny-
lated-peroxidase complex (Vectastain Elite ABC kit, Vector Laboratories, Peterborough, UK)
for 30 minutes.
To identify blood vessels in scaffolds implanted in mice, endogenous peroxidase activity of
sections was quenched with 3% H2O2 for 10 minutes. Sections were then subjected to enzy-
matic-mediated antigen retrieval with 0.1% Proteinase K (pH 7.8, Dako, Hamburg, Germany)
for 3 minutes. The sections were blocked with protein block solution (Dako) for 30 minutes,
and then incubated with rat anti-mouse CD31 (3 μg/mL, BD Biosciences, North Ryde,
Australia) for 60 minutes. Sections were then incubated with biotinylated rabbit anti-rat
IgG (4 μg/mL, Dako) for 30 minutes, followed by avidin-biotinylated-peroxidase complex
(Vectastain Elite ABC kit, Vector Laboratories).
To identify blood vessels in tissue constructs harvested from rat tissue engineering cham-
bers, sections were treated with 3% H2O2 and proteinase K (Dako) prior to incubation with
biotinylated Griffonia Simplicifolia lectin (6.67 μg/mL, B-1105, Vector Laboratories) overnight
at 4°C. The incubation of lectin was then followed by HRP-streptavidin (1.78 μg/mL; Dako)
treatment for 30 minutes.
To identify human cells, sections underwent heat-mediated antigen retrieval in citric acid
buffer (pH 6.0, 30 minutes at 95°C) followed by 3% H2O2 for 5 minutes. Sections were then
sequentially incubated in serum-free blocking solution (Thermo Fisher Scientific, MA, USA)
for 10 minutes, rabbit anti-Ku80 antibody (0.06 μg/mL; Abcam, MA, USA) or mouse anti-
human CD31 (4.1 μg/mL, Dako) overnight at 4°C, biotinylated goat-anti-rabbit secondary
antibody (7.5 μg/mL; Vector Laboratories) or biotinylated rabbit-anti-mouse secondary anti-
body (2.9 μg/mL; Dako) for 60 minutes and avidin-biotinylated-peroxidase complex
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(Vectastain Elite ABC kit, Vector Laboratories) for 30 minutes. In all sections, peroxidase activ-
ity was visualized with diaminobenzidine chromogen (Dako) and sections were counterstained
with hematoxylin before mounting in DPX mounting medium (VWR International, Poole,
UK).
Morphometric analysis of vascularization
Quantification of tissue vascularization and scaffold degradation were performed using video
microscopy with a computer-assisted stereo investigator system (MBF Bioscience, VT, USA)
[18,19]. For each sample, three cross-sectional sections—200 μm apart (scaffolds from in vivo
murine subcutaneous implantation) or 4 complete transverse sections (tissue constructs from
in vivo rat tissue engineering chambers) were counted with a 20x magnification objective.
Using systematic random sampling, 12-point grids (400 μm x 400 μm) were superimposed on
randomly selected fields representing 25% of the total area and each point within the grid was
recorded as positive or negative on the basis of CD31 staining vessels, lectin staining vessels or
scaffold. Percentage of vascular volume were determined by dividing the number of points in
each of the selected fields that fell randomly on vessels (CD31 or lectin positive capillaries
including the lumens) or scaffolds by the total number of points counted for that tissue section
and multiplied by 100. Absolute vascular volume or scaffold of rat tissue was calculated by mul-
tiplying the percentage of vascular volume or percentage of scaffold material by the total tissue
volume at harvest determined by volume displacement. All counting was completed by a
trained operator masked to the identity of the tissue samples.
Statistical analysis
Data are expressed as mean ± standard error of the mean (SEM). The mean data were analysed
with unpaired t-test or one-way analysis of the variance (ANOVA) with Tukey multiple com-
parison post-hoc test where appropriate. A value of p<0.05 was regarded as statistically
significant.
Results
Formation of capillary structures in collagen scaffolds seeded with
human endothelial cells in vitro
To assess whether collagen scaffolds can provide a viable platform for the growth of endothelial
cells, hMECs were cultured in fibrin filled scaffolds for 3 days. CD31+ capillary-like structures
were formed throughout the scaffolds cultured with hMECs for 3 days (n = 2, Fig 2A and 2B).
Collagen scaffold induces intrinsic vascularisation in a murine
subcutaneous implantation model
We assessed the degree of vascular infiltration of scaffolds harvested from mice at 1, 2, 4 and 8
weeks post-implantation (n = 4–6 from each time point). The scaffolds reduced in size the lon-
ger the implantation period (Fig 3A). Histological sections of scaffolds implanted for 1 week
showed evenly distributed pores with minimal cell infiltration. The number of infiltrated cells
gradually increased with longer implantation periods (2–8 weeks; Fig 3B). Within the scaffolds,
CD31+ capillary-like structures with clear lumens were observed at 2, 4 and 8 weeks but not at
1 week (Fig 3C). Quantification of CD31+ vessels within the scaffolds confirmed that vasculari-
zation was minimal at 1 week but gradually increased from 2 weeks and reached a maximum
percent vascular volume at 4 weeks (4.6±0.9% at 2 weeks, 8.2±0.7% at 4 weeks, 6.7±0.9% at 8
weeks; p<0.05 for each comparison vs. 0.04±0.04% at 1 week, n = 3–6; Fig 3D). The increase in
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CD31+ cells in the scaffold was accompanied by gradual degradation of scaffold material over
time (22.7±3.7% at 4 weeks, 31.3±3.5% at 8 weeks; p<0.05 for each comparison vs 83.4±1.5%
at 1 week, n = 3–6; Fig 3E). The extent of scaffold degradation plateaued at 4 weeks and colla-
gen scaffold material could still be found at 8 weeks post-implantation.
Fig 2. Capillary formation from human endothelial cells cultured in collagen scaffolds for 3 days. (A)
Human dermal microvascular endothelial cells formed CD31+ capillaries with clear luminal structures at 3
days in culture. (B) A higher magnification of an inset box in (A) with capillary-like structures identified by
arrows. Scale bar = 100 μm.
doi:10.1371/journal.pone.0149799.g002
Fig 3. Vascular infiltration in collagen scaffolds implanted in mice. (A) Appearance of scaffolds
harvested frommice at 1 and 4 weeks. Representative images of scaffold sections stained with haematoxylin
and eosin (B) or endothelial cell marker CD31 (C) at 1, 2, 4 and 8 weeks post-implantation. Percentage of
vascular volume (D) and percent of remaining collagen scaffold (E) at 1, 2, 4 and 8 weeks post-implantation
(n = 3–6 mice). *p<0.05 and **p<0.01 by one-way ANOVA with Turkey post-hoc test. Scale bar = 100 μm.
doi:10.1371/journal.pone.0149799.g003
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Collagen scaffold induces intrinsic vascularisation in a rat tissue
engineering model
An in vivo rat tissue engineering chamber was employed to assess the ability of collagen scaf-
folds to support an angiogenic response and new tissue formation (Fig 4A and 4B). Newly
formed blood vessels were identified by lectin staining (Fig 4C). Compared to control chambers
which contained fibrinogen gel alone, the absolute vascular volume was significantly higher in
constructs generated from chambers containing collagen scaffolds infiltrated with fibrinogen
gel (42.7±5.0 μL in collagen scaffold vs 22.5±2.3 μL in control; p<0.05, n = 7; Fig 4D). The per-
centage of vascular volume was similar between groups (40.7±2.5% in collagen scaffold vs 39.9
±4.1% in control; p>0.05, n = 7). No significant difference in total chamber tissue weight and
volume was found between groups (Fig 4E) and collagen scaffolds were completely degraded
by 4 weeks post-implantation.
Collagen scaffolds provide a bioactive cue for human ASCs in vitro and
in vivo
Twenty-four hours after seeded onto the collagen scaffold, human ASCs were found distrib-
uted evenly throughout the collagen scaffold (Fig 5A). SEM showed that adhered human ASCs
Fig 4. Tissue weight, volume and vascularity in tissue constructs generated in rat tissue engineering
chambers. (A) The polyacrylic chambers containing collagen scaffolds infiltrated with fibrinogen gel (circled)
or fibrinogen gel alone were placed around the femoral artery and vein in the groin region of rats. Scale
bar = 5 mm. (B) Representative photomicrograph of new tissues generated in the tissue engineering
chambers contained collagen scaffold infiltrated with fibrinogen gel (left) or fibrinogen gel alone (right) at 4
weeks post-implantation. (C) Representative images of tissue sections stained with blood vessel marker
lectin. Top two figures: fibrinogen alone (-scaffold), bottom two figures collagen scaffold with fibrinogen
(+scaffold). (D) The absolute vascular volume in vascularized tissues at 4 weeks post-implantation (n = 7).
(E) The weight and volume of tissue constructs harvested at 4 weeks post-implantation (n = 7). **p<0.01 by
unpaired t-test. Scale bars = 100 μm.
doi:10.1371/journal.pone.0149799.g004
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exhibited spindle shape morphology, and cell-cell and cell-scaffold interactions were observed
around the porous structure of the collagen scaffolds (Fig 5A). Moreover, the proliferation of
proangiogenic human ASCs [20] cultured in 3D collagen scaffolds and 2D culture was assessed
over a period of 21 days. Those ASCs cultured in 2D (1x106 cells/well in 12-well plate) were
confluent at 2 days after seeding but did not proliferate further for the next 21 days due to con-
tact inhibition. In contrast, human ASCs cultured in 3D collagen scaffolds continued to prolif-
erate throughout the 21 days in culture (Fig 5B and 5C).
To determine whether collagen scaffolds support the proangiogenic function of GFP-
labelled human ASCs in vivo, the formation of new vascularized tissue in the rat tissue engi-
neering chambers was compared between chambers containing scaffolds seeded with and with-
out GFP-labelled human ASCs. At 2 weeks post-implantation, the absolute vascular volume
was significantly higher in the ASCs group compared to control group (42.9±4.0 μL in the col-
lagen scaffold with human ASCs vs 25.7±1.9 μL in collagen scaffold alone; p<0.05, n = 4; Fig
6A). The percent vascular volume was increased in the ASC/scaffold group over the control
scaffold group (32.1±5.0% in the collagen scaffold with human ASCs vs 25.9±1.7% in collagen
scaffold alone; p>0.05, n = 4). No significant difference in total chamber tissue weight and
Fig 5. Morphology and growth of human ASCs cultured in 3D collagen scaffolds over 21 days. (A)
Representative images captured from 3D collagen scaffolds seeded with human ASCs for 24 hours:
haematoxylin and eosin (H&E) staining and scanning electron microscopy (SEM). The white arrow
demonstrates human ASCs attached to the collagen scaffold. (B) Representative images of GFP-expressed
human ASCs cultured in collagen scaffolds for 7 and 21 days. Scale bar = 200 μm. (C) The proliferation rate
of GFP-expressed human ASCs cultured in 3D collagen scaffolds and on 2D collagen-coated plates (n = 3).
**p<0.01 vs 2D culture by unpaired t-test.
doi:10.1371/journal.pone.0149799.g005
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volume was found between groups (Fig 6B and 6C). Staining with human-specific Ku80
showed that human ASCs were still present in the residual collagen scaffolds at 2 weeks post-
implantation (Fig 6D) but human cells had also migrated into the neotissues outside the scaf-
fold aligning close to the new blood vessels (Fig 6E). However, no human-specific CD31 posi-
tive cells were detected in the tissue constructs (data not shown).
Discussion
The present study demonstrated that the 3D collagen scaffolds can support extrinsic and
intrinsic vascularization using two different in vivo animal models, the murine subcutaneous
implant model (extrinsic vascularization) and the rat tissue engineering chamber model
(intrinsic vascularization). The collagen scaffolds support endothelial cell survival and permit-
ted significant capillary formation within their pores in vitro. Furthermore, the collagen scaf-
folds also provide structural and mechanical support for 3D cell culture in vitro and can be
employed as a bioactive cue for the delivery of human cells in vivo.
Collagen is one of the major ECM proteins that interacts with various growth factors and
cells, and has a chemotactic activity to endothelial cells [21] in the wound healing process [22].
Theoretically, collagen scaffolds can be employed as cell carriers and as reservoirs for growth
factors without compromising their activity which would be of great value to promote angio-
genesis and vascular stabilization for tissue engineering [23,24]. Indeed, we have previously
shown that exogenously added neuron cancer stem cells start to adhere to the scaffolds at day 1
and form a colony at day 3 [25]. In the present study, we have further demonstrated the cell
Fig 6. Tissue constructs engineered in rat tissue engineering chambers containing collagen scaffolds
seeded with human ASCs. (A) The absolute vascular volume in tissue constructs harvested at 2 weeks
post-implantation (n = 4). The total weight (B) and volume (C) of chamber tissue constructs harvested at 2
weeks post-implantation (n = 4). Human ASCs were identified by human-specific Ku80 (brown nucleus
staining) in (D) the collagen scaffold and (E) the tissue construct harvested at 2 weeks post-implantation.
**p<0.01 by unpaired t-test.
doi:10.1371/journal.pone.0149799.g006
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compatibility of these collagen scaffolds with human endothelial cells and human ASCs. The
human endothelial cells can be grown in the collagen scaffold and formed CD31+ capillary-like
structures in vitro suggesting that the scaffolds can form a pre-vascularized platform for cell-
based tissue growth for subsequent implantation. We also showed a greater growth of human
ASCs when cultured in the porous 3D collagen scaffolds rather than the conventional 2D cell
culture format. This was attributed to the interconnection of pores within the scaffolds provid-
ing more space to accommodate cell growth and allowing diffusion of nutrient, oxygen and
metabolites through the scaffolds. Therefore, the collagen scaffolds provide a biological ECM
microenvironment that supports growth of several human cell types including endothelial
cells, ASCs and neuronal cancer stem cells [25].
The collagen scaffolds employed in the present study might well provide a bioactive cue for
infiltrating cells, including endogenous endothelial cells, to induce vascularization of the
implants. The porous structure of the collagen scaffolds allows the diffusion of nutrients as well
as migration of cells [24], which are important features for vascularization. Xiao et al. [26] have
recently shown that endothelial cells tend to accumulate around the pore interconnection of
porous scaffolds, and it is the site where the cells migrate into the inner part of the scaffolds to
induce vascularization. As such, the porous structure of scaffolds facilitates vascularization,
and the collagen scaffolds are biocompatible when implanted in vivo in small animals. The
murine subcutaneous implant model is often used to study the biocompatibility of scaffolds
[27] as well as angiogenesis during wound healing [28]. An infiltration of host cells into the col-
lagen scaffolds was seen at week 1 and an accumulation of host cells at the central region
occurred from week 2. This time-dependent increased in cell infiltration correlated with an
increasing number of CD31+ capillaries indicating vascularization of the implanted scaffolds.
The gradual increased in vascularization of the implanted scaffolds was also found to be
accompanied by the degradation of scaffold matrix over 8 weeks without adverse inflammatory
response. These findings suggest that such scaffolds can integrate with the host tissues and pro-
vide a biodegradable environment for in vivo vascularization during a wound healing response
[24].
Fibrin gel has often been used as a hydrogel in many applications of tissue engineering [29]
such as skeletal muscle tissue [30] and cardiac tissue [31,32]. Fibrin gel can be derived from
human fibrinogen and can potentially be applied clinically. Autologous fibrin gel can be syn-
thesized from the patient’s own blood to minimise immune reaction [29] and this makes fibrin
gel an attractive hydrogel for tissue repair and regeneration. Moreover, fibrin, an active compo-
nent of the fibrinogen gel, has also been shown to be a pro-angiogenic factor that can enhance
angiogenesis via triggers the angiogenic such as VEGF [33,34]. However, fibrin gel has poor
mechanical properties render it susceptible to cell-mediated contraction and mechanical strain
when implanted in vivo [35]. Brougham et al. [35] recently addressed this problem by incorpo-
rating fibrin into a collagen-glycosaminoglycan matrix hence reducing the degree of cell-medi-
ated contraction as well as improving the viability of vascular smooth muscle cells. Similarly,
we showed that incorporating fibrin gel into the collagen scaffolds yielded a greater vascular
volume in the tissue constructs generated in an in vivo tissue engineering chamber compared
with fibrin gel alone. The increase in vascular volume was likely due to larger chamber tissue
volume of the constructs from the collagen scaffold group as the percentage of vascular volume
was similar between groups. Thus, the structural support provided by the collagen scaffolds
would synergise the growth of tissues in fibrin gel.
An alternative approach to using soluble growth factors to promote intrinsic vascularization
would be seeding scaffolds with pro-angiogenic cells [5–8]. Human ASCs have been known to
release a variety of pro-angiogenic cytokines and growth factors including interleukins, VEGF,
angiogenin, and fibroblast growth factor-2 under normoxic [36] and hypoxic [37] conditions.
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The level of cytokines and growth factors released from human ASCs has been found to be suf-
ficient to promote proliferation of human endothelial cells [36,37] and promote angiogenesis
in vivo [36]. Moreover, Wang et al. [20] recently developed a biocompatible polytetrfluoroethy-
lene filtration membrane to study the pro-angiogenic activity of human ASCs. This device was
used to encapsulate human ASCs to insulate the implanted cells from the host microenviron-
ment while allowing diffusion of soluble factors secreted from the cells. When implanted sub-
cutaneously in rats, ASC-laden devices resulted in higher number of blood vessels in the tissue
surrounding the devices and expressed higher levels of cytokines and growth factors such as
interleukin-10 and VEGF in comparison to acellular devices [20], confirming a pro-angiogenic
effect of human ASCs in vivo. We found that ASC-laden collagen scaffolds resulted in a higher
volume of blood vessels in tissue constructs in comparison to scaffolds without ASCs. At 2
weeks post-implantation, some implanted human ASCs remained in the collagen scaffolds
while others have migrated out of the scaffolds into the neotissues and localized in close prox-
imity to the host blood vessels. However, immunostaining with human-specific endothelial
marker CD31 did not detect positive cells in the tissue constructs suggesting that the increase
in vascular volume was likely attributed to the paracrine activity of the implanted human ASCs
on host tissues, rather than the differentiation of ASCs into endothelial cells.
Conclusions
We have demonstrated a 3D porous collagen scaffold material that is versatile, biocompatible,
biodegradable and has bioactivity that mimics the functions of natural ECM to support vascu-
larization in vitro and in vivo in different species (rat and mouse) and experimental models
(subcutaneous implant and tissue engineering chamber). Unique properties of the collagen
scaffolds which (1) provide structural support for cell infiltration and angiogenesis, (2) can be
used as a cell carrier for in vivo implantation, and (3) offer mechanical support to grow more
robust vascularized tissue grafts for tissue and organ repair.
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